Addressing Recent Failures in Immuno-Oncology Trials to Guide Novel Immunotherapeutic Treatment Strategies Shazia K. NakhodaAnthony J. Olszanski Leading Article 10 March 2020 Pages: 83 - 91
Addressing the Regulatory and Scientific Challenges with Generic Orally Inhaled Drug Products Bryan NewmanKimberly Witzmann Review Article 28 February 2020 Pages: 93 - 102
Critical Factors Shaping Strategy Development of an Innovative Medicine in Oncology Andriy KrendyukovSreekanth Gattu Review Article 27 February 2020 Pages: 103 - 112
Proposal for a New Stereochemically Informative Nonproprietary Drug Naming System Joseph Gal Original Research Article 19 February 2020 Pages: 113 - 126
Influence of Pharmaceutical Company Engagement Activities on the Decision to Prescribe: A Pilot Survey of UK Rare Disease Medicine Prescribers Ravi Jandhyala Original Research Article Open access 09 January 2020 Pages: 127 - 134
US Food and Drug Administration Safety Advisories and Reporting to the Adverse Event Reporting System (FAERS) Thomas J. MooreRichard L. MorrowBarbara Mintzes Original Research Article 16 March 2020 Pages: 135 - 140